Delivery Order SPE2DB24D1201-SPE2DB25FJDES
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of ORGOVYX 120 MG tablets in quantities of 30 units, with a contract ceiling value of $4,156.56. This non-competitive, firm fixed-price delivery order is set to conclude by July 31, 2025, and will be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania location. The award represents a continuation of the company's role as a critical pharmaceutical supplier to federal...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 11, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units, with a contract ceiling value of $2,771.04. The award represents a firm fixed-price delivery order with an ultimate completion date of August 1, 2025. This contract was competitively awarded without set-aside designation and is funded through the Defense Logistics Agency's Medical Supply Chain, a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30-count units, with a contract ceiling value of $1,385.52 and a completion date of October 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be performed at...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units. This competitive award, with no set-aside designation, carries a ceiling value of $1,385.52 and is structured as a firm fixed-price delivery order with an ultimate completion date of September 25, 2025. The award supports the federal government's pharmaceutical procurement needs through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ORGOVYX 120 mg tablets (30-count units) with a ceiling value of $4,156.56 under a firm fixed-price contract. This non-competitive delivery order, issued on June 2, 2025, represents a single pharmaceutical procurement to be fulfilled by June 24, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units, with a ceiling value of $1,385.52. This competitive award, utilizing firm fixed pricing, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units, valued at $1,385.52. This competitively awarded, firm fixed-price delivery order is due for completion by November 5, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition among qualified pharmaceutical suppliers....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 15, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $4,156.56 and an ultimate completion date of August 5, 2025. The contract was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $4,156.56 and a firm fixed price structure, with an ultimate completion date of October 6, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $4,156.56 to AmerisourceBergen Drug Corp for ORGOVYX 120 mg tablets (30-count units) on June 4, 2025, with an ultimate completion date of June 26, 2025. This firm fixed-price contract represents a non-competitive set-aside delivery against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The place...
- SPE2DB24D1201Indefinite Delivery Contract
- SPE2DB24D1201-SPE2DB25FJDESDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 25, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $5,542.08 and an ultimate completion date of July 17, 2025. The contract was competitively awarded with no set-aside designation, and performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. ORGOVYX is a prescription medication used in hormone therapy, reflecting the company's role as a critical pharmaceutical supplier for military and federal healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. As one of the nation's largest pharmaceutical distributors, AmerisourceBergen serves as a prime vendor for the Defense Health Agency and other federal healthcare programs, supplying an extensive range of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. The company's continued awards under this contract vehicle demonstrate its capability to meet federal procurement requirements through open competition and its critical role in supporting military healthcare operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 6/25/25 |